FROM: Cancer Imaging Program, National Cancer Institute, April, 2004. Electronic Newsletter, No. 72
CIP Web Site: http://cip.cancer.gov/
NIH - New Funding Initiatives
1. NOVEL TECHNOLOGIES FOR IN VIVO IMAGING (R21/R33) (NCI) (PA-04-095)
This Program Announcement (PA) replaces PAR-03-124. Deadlines are standard (2/1, 6/1, 10/1) with amended applications due one month later.
The NCI invites applications for the development and delivery of novel image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is primarily intended to facilitate the proof-of-feasibility, development, and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases, and, secondarily, to facilitate limited evaluation studies to show proof-of-concept and functionality.
2. NOVEL TECHNOLOGIES FOR IN VIVO IMAGING (SBIR/STTR)(NCI, NIEHS, NIDDK, NINDS) (PA-04-094)
This Program Announcement (PA) replaces PAR-03-125. Deadlines are standard (4/1, 8/1, 12/1). The NCI, NIEHS, NIDDK, and NINDS invite applications for the development and delivery of novel in vivo image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy. Applications may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is primarily intended to facilitate the proof-of-feasibility, development, and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions and treatments of various diseases, and, secondarily, to facilitate limited evaluation studies to show proof-of-concept and functionality.
3. NOTICE OF ADDITIONAL RECEIPT DATES FOR THE INTEGRATIVE MOLECULAR ANALYSIS TECHNOLOGIES (IMAT) REQUESTS FOR APPLICATIONS (NCI) (NOT-CA-04-013)
This notice is to inform potential applicants that the NCI plans to re-issue the IMAT requests for applications (RFAs) (CA-05-002, CA-05-003, and CA-05-004; CA-05-006, CA-05-007, and CA-05-008) in 2005 and 2006.
The anticipated receipt dates are as follows:
2005: February 17; June 17; and October 18.
2006: February 17; June 19; and October 18.
4. NIH ROADMAP
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
In particular see
MOLECULAR LIBRARIES SCREENING CENTERS NETWORK (MLSCN)(Roadmap) (RFA-RM-04-017)
LETTER OF INTENT RECEIPT DATE: July 26, 2004
APPLICATION RECEIPT DATE: August 24, 2004
The Institutes and Centers (ICs) of the NIH invite applications from investigators interested in participating in an NIH Roadmap pilot program to establish the Molecular Libraries Screening Centers Network (MLSCN). The MLSCN will be a national resource capable of providing innovative high throughput molecular screening (HTS) approaches for the identification of small organic molecules (compounds) that are active in biological assays, and synthetic chemistry to improve the utility of these molecules as bioactive probes for in vitro, and potentially in vivo, studies of normal and abnormal physiology of cells, organs, model systems, and/or organisms.
The NIH Center for Scientific Review has reorganized the review panels to which the investigator-initiated imaging applications are sent. BMIT is the former DMG; MEDI is the former RNM Look at the web site to see the Surgical Sciences, Biomedical Imaging, and Bioengineering IRB (SBIB) information with links to the Study Sections.
INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY
Next Due Date for Requests - June 8 (for July 27, 2004 meeting)
The ICBIO is a multi-agency group designed to serve as a sounding board for investigators and manufacturers attempting to take emerging medical imaging technology to market. The ICBIO provides advice on projects or project proposals brought voluntarily by investigators and technology/device developers in industry and academia. It offers a multi-agency perspective to the communication with government agencies that is already available to investigators and companies.
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
CANCER IMAGING 2004: MR, CT & PET
May 23-25, 2004, Sheraton Chicago Hotel & Towers, Chicago, Illinois ULR: http://www.worldclasscme.com
SOCIETY OF NUCLEAR MEDICINE 51st ANNUAL MEETING
June 19-23, 2004, Pennsylvania Convention Center, Philadelphia, PA.
NCI Cancer Imaging Program Booth Number 115
BECON/BISTIC SYMPOSIUM: Informatics for Clinical Decision-making in the 21st Century
June 21-22, 2004, Natcher Auditorium, NIH Campus, Bethesda, MD
6th Annual NIH SBIR/STTR Conference
June 23-24, 2004, Natcher Auditorium, NIH Campus, Bethesda, MD
CARS 2004 COMPUTER ASSISTED RADIOLOGY AND SURGERY
June 23-26, 2004, Hilton & Towers Hotel, Chicago, IL, USA
SEVENTEENTH IEEE SYMPOSIUM ON COMPUTER BASED MEDICAL SYSTEMS (CBMS 2004)
June 24-25, 2004, Hotel Four Points by Sheraton, Bethesda, Maryland
FIRST INTERNATIONAL SYMPOSIUM ON CANCER METASTASIS AND THE LYMPHOVASCULAR SYSTEM: THE BASIS FOR RATIONAL THERAPY
July 8-10, 2004, San Francisco, CA, USA
THIRD ANNUAL MEETING OF THE SOCIETY FOR MOLECULAR IMAGING
September 9-12, 2004, Adam's Mark Hotel, St. Louis, MO
FOURTH INTER-INSTITUTE WORKSHOP ON OPTICAL DIAGNOSTIC IMAGING FROM BENCH TO BEDSIDE
National Institutes of Health, 20-22 September 2004, Natcher Auditorium, National Institutes of Health, Bethesda, Maryland
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507